Patents by Inventor James Economou

James Economou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MART-1 T cell receptors
    Patent number: 8552150
    Abstract: T-cell receptors that recognize MART-1 antigen are provided. The TCRs can be used, for example, to treat patients suffering from melanoma.
    Type: Grant
    Filed: February 17, 2012
    Date of Patent: October 8, 2013
    Assignees: California Institute of Technology, Regents of the University of California
    Inventors: Lili Yang, David Baltimore, Pin Wang, James Economou, Antoni Ribas
  • MART-1 T CELL RECEPTORS
    Publication number: 20120196361
    Abstract: T-cell receptors that recognize MART-1 antigen are provided. The TCRs can be used, for example, to treat patients suffering from melanoma.
    Type: Application
    Filed: February 17, 2012
    Publication date: August 2, 2012
    Applicants: REGENTS OF THE UNIVERSITY OF CALIFORNIA, CALIFORNIA INSTITUTE OF TECHNOLOGY
    Inventors: Lili Yang, David Baltimore, Pin Wang, James Economou, Antoni Ribas
  • MART-1 T cell receptors
    Patent number: 8119772
    Abstract: T-cell receptors that recognize MART-1 antigen are provided. The TCRs can be used, for example, to treat patients suffering from melanoma.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: February 21, 2012
    Assignees: California Institute of Technology, Regents of the University of California
    Inventors: Lili Yang, David Baltimore, Pin Wang, James Economou, Antoni Ribas
  • MART-1 T CELL RECEPTORS
    Publication number: 20080199424
    Abstract: T-cell receptors that recognize MART-1 antigen are provided. The TCRs can be used, for example, to treat patients suffering from melanoma.
    Type: Application
    Filed: September 28, 2007
    Publication date: August 21, 2008
    Inventors: Lili Yang, David Baltimore, Pin Wang, James Economou, Antoni Ribas
  • Method and compositions for treating hepatocellular cancer
    Publication number: 20060286075
    Abstract: A method for preventing or for treating cancer in a mammal, where the cancer cells express at least a part of an alpha fetoprotein molecule at the cell surface. The method comprises creating an immune response in the mammal to at least part of the amino acid sequence of an alpha fetoprotein molecule, where the immune response comprises activating alpha fetoprotein peptide specific T lymphocytes against the cancer cells, and where the part of the alpha fetoprotein molecule is selected from the group consisting of residues 137-145 of SEQ ID NO:2, and residues 325-334 of SEQ ID NO:2 and a combination of the preceeding.
    Type: Application
    Filed: August 16, 2006
    Publication date: December 21, 2006
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: James Economou, Lisa Butterfield, Antoni Ribas Bruguera